Literature DB >> 16465218

Zinc inhibits apoptosis upstream of ICE/CED-3 proteases rather than at the level of an endonuclease.

C M Wolf1, S J Morana, A Eastman.   

Abstract

Apoptosis is commonly associated with DNA digestion, but it remains controversial as to which endonuclease is involved. The ability of zinc to inhibit DNA digestion in intact cells, and inhibit a Ca2+/Mg2+-dependent endonuclease in cell lysates, has been used frequently to suggest this is the endonuclease involved. However, zinc has many other effects on cells, and here it is shown that zinc also prevents many upstream events in apoptosis. These studies were performed in human ML-1 cells following incubation with etoposide. During apoptosis, these cells undergo intracellular acidification, increased accumulation of Hoechst 33342, DNA digestion and chromatin condensation. Zinc inhibited all of these events. An upstream event in apoptosis is activation of ICE/CED-3 proteases which is commonly observed as proteolysis of a substrate protein, poly(ADP-ribose) polymerase (PARP). The ICE/CED-3 proteases are themselves activated by proteolysis, and this was detected here by cleavage of one family member CPP32. Zinc prevented cleavage of both CPP32 and PARP. We recently demonstrated that dephosphorylation of the retinoblastoma susceptibility protein Rb was a marker of an event even further upstream in apoptosis; zinc was also found to inhibit Rb dephosphorylation. Therefore, zinc must protect cells at a very early step in the apoptotic pathway, and not as a direct inhibitor of an endonuclease.

Entities:  

Year:  1997        PMID: 16465218     DOI: 10.1038/sj.cdd.4400218

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  4 in total

1.  L-DNase II, a molecule that links proteases and endonucleases in apoptosis, derives from the ubiquitous serpin leukocyte elastase inhibitor.

Authors:  A Torriglia; P Perani; J Y Brossas; E Chaudun; J Treton; Y Courtois; M F Counis
Journal:  Mol Cell Biol       Date:  1998-06       Impact factor: 4.272

2.  Anticancer activity and protein phosphatase 1 and 2A inhibition of a new generation of cantharidin analogues.

Authors:  Jennette A Sakoff; Stephen P Ackland; Monique L Baldwin; Mirella A Keane; Adam McCluskey
Journal:  Invest New Drugs       Date:  2002-02       Impact factor: 3.850

3.  Mechanism of zinc-mediated inhibition of caspase-9.

Authors:  Kristen L Huber; Jeanne A Hardy
Journal:  Protein Sci       Date:  2012-05-24       Impact factor: 6.725

Review 4.  Selenium targets resistance biomarkers enhancing efficacy while reducing toxicity of anti-cancer drugs: preclinical and clinical development.

Authors:  Yousef Zakharia; Arup Bhattacharya; Youcef M Rustum
Journal:  Oncotarget       Date:  2018-01-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.